Meitav Investment House’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-13
Closed -$57K 431
2020
Q1
$57K Buy
+13
New +$57K ﹤0.01% 364
2019
Q4
Sell
-15
Closed -$107K 469
2019
Q3
$107K Hold
15
0.01% 433
2019
Q2
$94K Hold
15
0.01% 419
2019
Q1
$123K Sell
15
-35
-70% -$287K 0.01% 371
2018
Q4
$278K Buy
50
+1
+2% +$5.56K 0.02% 271
2018
Q3
$422K Buy
49
+1
+2% +$8.61K 0.02% 345
2018
Q2
$388K Hold
48
0.02% 348
2018
Q1
$247K Hold
48
0.01% 301
2017
Q4
$244K Buy
+48
New +$244K 0.01% 183